BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 18547944)

  • 1. Factors predicting bacterial involvement in severe acute exacerbations of chronic obstructive pulmonary disease.
    Nseir S; Cavestri B; Di Pompeo C; Diarra M; Brisson H; Lemyze M; Roussel-Delvallez M; Durocher A
    Respiration; 2008; 76(3):253-60. PubMed ID: 18547944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Procalcitonin as a prognostic factor in severe acute exacerbation of chronic obstructive pulmonary disease.
    Rammaert B; Verdier N; Cavestri B; Nseir S
    Respirology; 2009 Sep; 14(7):969-74. PubMed ID: 19659517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple-drug-resistant bacteria in patients with severe acute exacerbation of chronic obstructive pulmonary disease: Prevalence, risk factors, and outcome.
    Nseir S; Di Pompeo C; Cavestri B; Jozefowicz E; Nyunga M; Soubrier S; Roussel-Delvallez M; Saulnier F; Mathieu D; Durocher A
    Crit Care Med; 2006 Dec; 34(12):2959-66. PubMed ID: 17012911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Procalcitonin and C-reactive protein cannot differentiate bacterial or viral infection in COPD exacerbation requiring emergency department visits.
    Chang CH; Tsao KC; Hu HC; Huang CC; Kao KC; Chen NH; Yang CT; Tsai YH; Hsieh MJ
    Int J Chron Obstruct Pulmon Dis; 2015; 10():767-74. PubMed ID: 25926728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study.
    Daubin C; Parienti JJ; Vabret A; Ramakers M; Fradin S; Terzi N; Freymuth F; Charbonneau P; du Cheyron D
    BMC Infect Dis; 2008 Oct; 8():145. PubMed ID: 18947382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The changes and clinical implications of serum procalcitonin in acute exacerbations of chronic obstructive pulmonary disease].
    Chang C; Yao WZ; Chen YH; Liu ZY; Zhang XW
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jul; 29(7):444-7. PubMed ID: 17045042
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is it possible to reduce the use of antibiotics in severe exacerbations of chronic obstructive pulmonary disease?
    Miravitlles M
    Respiration; 2008; 76(3):249-50. PubMed ID: 18824884
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum Procalcitonin as a Biomarker for the Prediction of Bacterial Exacerbation and Mortality in Severe COPD Exacerbations Requiring Mechanical Ventilation.
    Ergan B; Şahin AA; Topeli A
    Respiration; 2016; 91(4):316-24. PubMed ID: 27081845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease.
    Lacoma A; Prat C; Andreo F; Lores L; Ruiz-Manzano J; Ausina V; Domínguez J
    Int J Chron Obstruct Pulmon Dis; 2011; 6():157-69. PubMed ID: 21468168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteria associated with acute exacerbations of chronic obstructive pulmonary disease requiring mechanical ventilation and antimicrobial management in Respiratory Care Unit of Central Chest Institute of Thailand.
    Siripataravanit S; Phaicharoen R; Termsetcharoen S; Klangprapun N
    J Med Assoc Thai; 2012 Aug; 95 Suppl 8():S11-8. PubMed ID: 23130469
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Procalcitonin levels and bacterial aetiology among COPD patients admitted to the ICU with severe pneumonia: a prospective cohort study.
    Daubin C; Parienti JJ; Fradin S; Vabret A; Ramakers M; Terzi N; Freymuth F; Charbonneau P; du Cheyron D
    BMC Infect Dis; 2009 Sep; 9():157. PubMed ID: 19772586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic treatment of exacerbations of COPD: a randomized, controlled trial comparing procalcitonin-guidance with standard therapy.
    Stolz D; Christ-Crain M; Bingisser R; Leuppi J; Miedinger D; Müller C; Huber P; Müller B; Tamm M
    Chest; 2007 Jan; 131(1):9-19. PubMed ID: 17218551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sputum purulence-guided antibiotic use in hospitalised patients with exacerbations of COPD.
    Soler N; Esperatti M; Ewig S; Huerta A; Agustí C; Torres A
    Eur Respir J; 2012 Dec; 40(6):1344-53. PubMed ID: 22523352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of semi-quantitative endotracheal aspirates to quantitative non-bronchoscopic bronchoalveolar lavage in diagnosing ventilator-associated pneumonia.
    Fujitani S; Cohen-Melamed MH; Tuttle RP; Delgado E; Taira Y; Darby JM
    Respir Care; 2009 Nov; 54(11):1453-61. PubMed ID: 19863828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prediction model for bacterial etiology in acute exacerbations of COPD.
    Lode H; Allewelt M; Balk S; De Roux A; Mauch H; Niederman M; Schmidt-Ioanas M
    Infection; 2007 Jun; 35(3):143-9. PubMed ID: 17565454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microbiogical data, but not procalcitonin improve the accuracy of the clinical pulmonary infection score.
    Jung B; Embriaco N; Roux F; Forel JM; Demory D; Allardet-Servent J; Jaber S; La Scola B; Papazian L
    Intensive Care Med; 2010 May; 36(5):790-8. PubMed ID: 20217042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein in outpatients with acute exacerbation of COPD: its relationship with microbial etiology and severity.
    Gallego M; Pomares X; Capilla S; Marcos MA; Suárez D; Monsó E; Montón C
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2633-2640. PubMed ID: 27799762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: a randomized noninferiority trial.
    Verduri A; Luppi F; D'Amico R; Balduzzi S; Vicini R; Liverani A; Ruggieri V; Plebani M; Barbaro MP; Spanevello A; Canonica GW; Papi A; Fabbri LM; Beghè B;
    PLoS One; 2015; 10(3):e0118241. PubMed ID: 25760346
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute exacerbations of chronic obstructive pulmonary disease with low serum procalcitonin values do not benefit from antibiotic treatment: a prospective randomized controlled trial.
    Wang JX; Zhang SM; Li XH; Zhang Y; Xu ZY; Cao B
    Int J Infect Dis; 2016 Jul; 48():40-5. PubMed ID: 27155210
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive value of broncho-alveolar lavage fluid Gram's stain in the diagnosis of ventilator-associated pneumonia: a prospective study.
    Goldberg AE; Malhotra AK; Riaz OJ; Aboutanos MB; Duane TM; Borchers CT; Martin N; Ivatury RR
    J Trauma; 2008 Oct; 65(4):871-6; discussion 876-8. PubMed ID: 18849805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.